|Articles|July 1, 2016
- Pharmaceutical Executive-07-01-2016
- Volume 36
- Issue 7
Pharmaceutical Executive, July 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Keeper of the Name: Bayer's Habib Dableover 9 years ago
Worlds Beyond the Clinicover 9 years ago
'PRIME' Time for Medicines in the EUover 9 years ago
Pill Countersover 9 years ago
Country Report: Italy, Part 2Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Insilico Medicine Enters $120 Million Drug Development Collaboration with Qilu Pharmaceuticals to Advance Cardiometabolic Therapies
2
FDA Approves Yuvezzi to Treat Presbyopia in Adults
3
Public Citizen Files Suit Against Trump Administration for Undisclosed Details of Pfizer and Eli Lilly Drug-Pricing Deals: Report
4
Pharma and MedTech Rarely Collide. That Might Be the Biggest Miss in Healthcare
5